Anika Therapeutics, Inc. specializes in the development, manufacture and commercialization of therapeutic pharmaceuticals and medical devices. These products are used in eye surgery and for the treatment of joint diseases, including osteoarthritis (OA), a chronically painful disease that slowly degenerates the cartilage lining the body¹s movable joints. The company is also developing a patented new therapy to prevent surgical adhesions and another to inhibit the spread of tumor cells.
Anika¹s product portfolio and research pipeline utilizes hyaluronic acid (HA), a non-toxic and non-inflammatory biopolymer found in tissues throughout the body. HA enhances joint function and coats, protects, cushions and lubricates soft tissues. Anika has developed prioprietary manufacturing processes for the extraction of medical grade, high molecular weight HA rooster and hen combs.